72.19.Z - Other research and experimental development on natural sciences and engineering
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
62.01.Z - Computer programming activities
62.09.Z - Other information technology and computer service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -3,4 | -3,3 | -1,1 | 66,7 |
Gross profit (loss) | -3,4 | -3,3 | -1,1 | 66,7 |
EBITDA | -3,4 | -3,3 | -1,1 | 66,7 |
Short time liabilities | 4,5 | 7,7 | 9 | 17,1 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | -3,6 | -6,9 | -8 | -15,9 |
Operating profit (EBIT) | -3,4 | -3,3 | -1,1 | 66,7 |
Assets | 0,9 | 0,8 | 1 | 26,4 |
Net profit (loss) | -3,4 | -3,3 | -1,1 | 66,7 |
Cash | 0,9 | 0,8 | 1 | 26,4 |
Liabilities and provisions for liabilities | 4,5 | 7,7 | 9 | 17,1 |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 0,9 | 0,8 | 1 | 26,4 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 95,5 | 47,9 | 13,8 | -34,1 |
Equity capital to total assets | -382 | -840,1 | -770,5 | 69,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.20747137069702148 | 0.10636910051107407 | 0.11487890034914017 | 0 |
Net dept to EBITDA | -0.8928526639938354 | -1.8706493377685547 | -6.792209148406982 | -4,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane